New discovery.,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 9
Published: Dec. 31, 2024
Diabetic
encephalopathy
(DE)
is
a
common
complication
in
diabetic
patients,
closely
linked
to
abnormal
immune
system
responses
that
drive
neuroinflammation,
neurodegeneration,
and
blood-brain
barrier
dysfunction.
Studies
indicate
cells,
inflammatory
mediators,
their
associated
pathological
mechanisms
play
critical
roles
causing
neuronal
damage
cognitive
decline
DE.
Here,
summarize
the
recent
progress,
56
relevant
articles
published
within
last
decade
were
selected
from
PubMed
search
using
keyword
“immune
response
encephalopathy.”
A
literature
review
was
used
understand
immune-related
cells
processes,
therapeutic
drugs
targeting
for
DE
treatment,
so
as
importance
of
regulation
pathogenesis
potential
strategies
drug
targets.
Moreover,
future
research
should
focus
on
elucidating
precise
regulatory
develop
targeted
treatments
aimed
at
improving
neurological
function
quality
life
patients
with
Acta Biochimica Polonica,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 22, 2023
Diabetes
mellitus
is
one
of
the
important
independent
risk
factors
for
development
neurological
disorders
such
as
ischemic
stroke,
transient
attacks,
vascular
dementia
and
neurodegenerative
processes.
Hyperglycemia
plays
a
crucial
role
trigger
in
pathogenesis
these
disorders.
In
this
review,
we
summarize
existing
data
on
molecular
mechanisms
diabetic
encephalopathy
development,
consider
features
oxidative
nitrosative
stresses,
changes
thiol-disulfide
system,
well
mitochondrial
endothelial
dysfunction
diabetes.
We
focus
HSP
70
cellular
responses
encephalopathy.
HSP70
protein
an
component
endogenous
system
neuroprotection.
It
acts
intracellular
chaperone,
providing
folding,
retention,
transport
synthesized
proteins,
their
degradation
under
both
normoxic
stress-induced
denaturation
conditions.
can
be
considered
marker
promising
therapeutic
target
treatment
diabetes
mellitus.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 14, 2025
Rhizoma
Coptidis
(RC)
is
an
edible
and
medicinal
herb
with
anti-hyperglycemia,
which
has
potential
application
in
the
prevention
of
diabetic
encephalopathy
(DE).
However,
its
efficacy
underlying
mechanism
DE
have
not
been
elucidated
yet.
The
objective
current
study
to
investigate
preventive
effect
RC
on
DE,
thereby
focusing
target
through
method
network
pharmacology
molecular
docking.
Sixty
4-week-old,
male
C57BL/6
mice
were
randomly
allocated
six
groups:
control,
model,
metformin
(200
mg/kg),
RCL
(0.75
g/kg),
RCM
(1.5
RCH
(3
g/kg).
DE-model
induced
by
streptozocin
combined
a
high-fat
diet.
In
addition,
neuroprotective
was
determined
both
vivo
vitro.
Network
analysis
used
screen
RC.
Thereafter,
action
explored
docking
prediction
Western
blot
analysis.
An
patients
performed
validate
it
from
another
perspective.
results
showed
that
cognitive
state
model
improved
neuronal
injury
ameliorated
after
administration.
Active
compounds
RC,
berberine
coptisine,
found
ameliorate
HT22
high
glucose.
suggest
voltage-gated
sodium
channel
subtypes
(Nav1.1,
Nav1.2,
Nav1.6)
may
be
targets
for
DE.
Furthermore,
revealed
significantly
upregulated
Nav1.1
while
Nav1.6
could
not.
serum
related
status
patients,
can
as
diagnostic
index
mild
moderate-severe
functional
food
or
adjuvant
drug
prevention,
Nav1.2
are
promising
intervention
targets.
BioFactors,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 16, 2024
Abstract
Despite
the
observation
of
diabetes‐induced
brain
tissue
damage
and
impaired
learning
memory,
underlying
mechanism
remains
elusive,
effective,
targeted
therapeutics
are
lacking.
Notably,
NLRP3
inflammasome
is
highly
expressed
in
hippocampus
diabetic
individuals.
Nerolidol,
a
naturally
occurring
compound
with
anti‐inflammatory
antioxidant
properties,
has
been
identified
as
potential
therapeutic
option
for
metabolic
disorders.
However,
ameliorative
capacity
nerolidol
on
hippocampal
injury
its
remain
unclear.
Network
pharmacology
molecular
docking
was
used
to
predict
signaling
pathways
targets
treatment
diabetes.
Then
established
rat
model
using
streptozotocin
(STZ)
combined
high‐fat
diet
administered.
Morris
water
maze
assess
spatial
memory
capacity.
Hematoxylin
eosin
Nissl
staining
detect
neuronal
hippocampus.
Transmission
electron
microscopy
extent
mitochondria,
endoplasmic
reticulum
(ER)
synapses.
Immunofluorescence
GFAP,
IBA1,
expression
Western
blot
apoptosis
(Bcl‐2,
BAX,
Cleaved‐Caspase‐3);
synapses
(postsynaptic
densifying
protein
95,
SYN1,
Synaptophysin);
mitochondria
(DRP1,
OPA1,
MFN1,
MFN2);
ER
(GRP78,
ATF6,
CHOP,
caspase‐12);
(NLRP3,
ASC,
caspase‐1);
inflammatory
cytokines
(IL‐18,
IL‐1β,
TNF‐α);
AKT
(P‐AKT);
mitogen‐activated
kinase
(MAPK)
pathway
(P‐ERK,
P‐p38,
P‐JNK)
related
expression.
showed
that
nerolidol's
possible
mechanisms
treating
diabetes
MAPK/AKT
effects.
Animal
experiments
demonstrated
could
improve
blood
glucose,
lipids,
rats.
Furthermore,
synaptic,
mitochondrial,
ultrastructure
rats
by
potentially
affecting
ER‐related
proteins.
Further
studies
revealed
decreased
neuroinflammation,
factor
while
also
decreasing
MAPK
enhancing
improves
cannot
be
shown
cognitive
function.
In
conclusion,
our
study
reveals
first
time
can
ameliorate
damage,
ER,
mitochondrial
we
suggest
may
inhibit
affected
AKT.
These
findings
provide
new
experimental
basis
use
associated
disease.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Oct. 14, 2024
Diabetic
encephalopathy
(DE)
is
a
severe
complication
of
diabetes,
but
its
pathogenesis
remains
unclear.
This
study
aimed
to
investigate
the
roles
and
underlying
mechanisms
high
glucose
(HG)-
advanced
glycosylation
end
product
(AGE)-induced
oxidative
stress
(OS)
in
cognitive
decline
DE.
The
DE
mouse
model
was
established
using
high-fat
diet
streptozotocin,
functions
were
evaluated
Morris
Water
Maze,
novel
object
recognition,
Y-maze
test.
results
revealed
increased
reactive
oxygen
species
(ROS)
generation,
mitophagy
inhibition,
decreased
prohibitin
2
(PHB2)
expression
hippocampal
neurons
mice
HG-
or
AGE-treated
HT-22
cells.
However,
overexpression
PHB2
reduced
ROS
reversed
improved
mitochondrial
function
cells
ameliorated
decline,
structural
damage,
inhibition
mice.
Further
analysis
that
Kelch-like
ECH-associated
protein
1
(Keap1)-nuclear
factor
erythroid
2-related
(Nrf2)
pathway
involved
AGE-mediated
downregulation
These
demonstrate
AGE-induced
OS
inhibits
via
Keap1-Nrf2-PHB2
pathway,
thereby
contributing
Diabetes
mellitus
(DM)
is
the
most
common
metabolic
disease
in
humans,
and
its
prevalence
increasing
worldwide
parallel
with
obesity
pandemic.
A
lack
of
insulin
or
resistance,
consequently
hyperglycemia,
leads
to
many
systemic
disorders,
among
which
diabetic
encephalopathy
(DE)
a
long-term
complication
central
nervous
system
(CNS),
characterized
by
cognitive
impairment
motor
dysfunctions.
The
role
oxidative
stress
neuroinflammation
pathomechanism
DE
has
been
proven.
Fractalkine
(CX3CL1)
unique
properties
as
an
adhesion
molecule
chemoattractant,
acting
on
only
receptor,
CX3CR1,
it
regulates
activity
microglia
physiological
states
neuroinflammation.
Depending
clinical
context,
CX3CL1-CX3CR1
signaling
may
have
neuroprotective
effects
inhibiting
inflammatory
process
or,
conversely,
maintaining/intensifying
inflammation
neurotoxicity.
This
review
discusses
evidence
supporting
that
pair
other
neurotoxic.
Interrupting
vicious
cycle
within
neuron-microglia
interactions
be
therapeutic
goal
limiting
response.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(14), P. 7527 - 7527
Published: July 9, 2024
Diabetes
mellitus
(DM)
is
the
most
common
metabolic
disease
in
humans,
and
its
prevalence
increasing
worldwide
parallel
with
obesity
pandemic.
A
lack
of
insulin
or
resistance,
consequently
hyperglycemia,
leads
to
many
systemic
disorders,
among
which
diabetic
encephalopathy
(DE)
a
long-term
complication
central
nervous
system
(CNS),
characterized
by
cognitive
impairment
motor
dysfunctions.
The
role
oxidative
stress
neuroinflammation
pathomechanism
DE
has
been
proven.
Fractalkine
(CX3CL1)
unique
properties
as
an
adhesion
molecule
chemoattractant,
acting
on
only
receptor,
CX3CR1,
it
regulates
activity
microglia
physiological
states
neuroinflammation.
Depending
clinical
context,
CX3CL1-CX3CR1
signaling
may
have
neuroprotective
effects
inhibiting
inflammatory
process
or,
conversely,
maintaining/intensifying
inflammation
neurotoxicity.
This
review
discusses
evidence
supporting
that
pair
other
neurotoxic.
Therefore,
interrupting
vicious
cycle
within
neuron–microglia
interactions
promoting
neurotoxic
axis
be
therapeutic
goal
limiting
response.
However,
optimal
approach
prevent
simply
tight
glycemic
control,
because
elimination
dysglycemic
CNS
abolishes
fundamental
mechanisms
induce
this
cycle.
Biomolecules,
Journal Year:
2023,
Volume and Issue:
13(9), P. 1325 - 1325
Published: Aug. 29, 2023
The
pathological
consequences
of
type
2
diabetes
mellitus
(T2DM)
also
involve
the
central
nervous
system;
indeed,
T2DM
patients
suffer
from
learning
and
memory
disabilities
with
a
higher
risk
developing
dementia.
Although
several
factors
have
been
proposed
as
possible
contributors,
how
neuroactive
steroids
gut
microbiome
impact
brain
pathophysiology
in
remain
unexplored.
On
this
basis,
male
Zucker
diabetic
fatty
(ZDF)
rats,
we
studied
whether
alters
abilities
using
novel
object
recognition
test,
steroid
levels
by
liquid
chromatography-tandem
mass
spectrometry,
hippocampal
parameters
molecular
assessments,
composition
16S
next-generation
sequencing.
Results
obtained
reveal
that
worsens
these
are
correlated
increased
corticosterone
plasma
decrease
allopregnanolone
hippocampus,
where
neuroinflammation,
oxidative
stress,
mitochondrial
dysfunction
were
reported.
Interestingly,
our
analysis
highlighted
small
group
taxa
strictly
related
to
both
impairment
levels.
Overall,
data
underline
an
interesting
role
for
microbiota
may
represent
candidates
development
therapeutic
strategies.
Fundamental and Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
9(2), P. 94 - 102
Published: June 21, 2024
Type
1
diabetes
mellitus
is
a
chronic
autoimmune
disease
with
onset
in
childhood
and
adolescence.
Neurological
disorders
are
among
the
most
frequent
complications
of
type
might
lead
to
cognitive
impairment
termed
as
diabetic
encephalopathy.
Besides
regulating
blood
glucose,
insulin
have
neuroprotective
pro-cognitive
effects
through
its
action
on
receptors
brain,
promoting
production
neurotransmitters,
long-term
potentiation,
synaptic
plasticity,
neuronal
differentiation.
By
enhancing
abovementioned
processes
responsible
for
learning
memory,
improves
functioning.
Insulin
deficiency
triggers
dysfunction
encephalopathy
via
mitochondrial
dysfunction,
oxidative
stress,
disorganisation
glucose
metabolism
which
alter
functioning
transporter
proteins
induce
pericyte
loss,
ultimately
compromising
integrity
blood-brain
barrier.
Intranasal
delivery
exogenous
insulin,
bypasses
bloodbrain
barrier,
may
serve
an
efficient
therapeutic
strategy
correcting
patients
Further
research
needed
uncover
understand
functions
mellitus.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
179, P. 117397 - 117397
Published: Sept. 3, 2024
Celastrol,
the
primary
constituent
of
Tripterygium
wilfordii,
has
demonstrated
neuroprotective
properties
in
rats
with
dementia
by
reducing
inflammation.
A
high-fat
diet
and
streptozotocin
injection
were
utilized
to
establish
a
diabetic
rat
model,
which
was
then
employed
investigate
possible
protective
effect
celastrol
against
development
diabetes-induced
learning
memory
deficits.
Afterwards,
experimental
animals
received
dose
gavage
(4
mg/kg/d).
An
animal
study
showed
that
enhanced
insulin
sensitivity
glucose
tolerance
rats.
In
Morris
water
maze
test,
diabetes
performed
poorly
terms
spatial
memory;
treatment
improved
these
outcomes.
Additionally,
administration
downregulated
expression
inflammatory-related
proteins
(NF-κB,
IKKα,
TNF-α,
IL-1β,
IL-6)
greatly
reduced
generation
Aβ
hippocampus
tissue.
Moreover,
signaling
pathway-related
PI3K,
AKT,
GSK-3β
significantly
upregulated
after
administered.
Also,
prevented
damage
brain
structures
increased
synthesis
synaptic
like
PSD-95
SYT1.
conclusion,
exerts
modulating
system
inflammatory
responses,
helps
ameliorate
cognitive
impairment
associated
diabetes.